SKY-0515 takes an interesting approach to treating HD. Rather than targeting just one aspect of the disease, it reduces levels of two proteins involved in HD biology. The first is expanded huntingtin, ...
The FDA has accepted uniQure’s application for AMT-130 (now called ifezuntirgene inilparvovec), an experimental gene therapy ...
October was another busy month in Huntington’s disease (HD) research! We learned more about often-overlooked symptoms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results